clinical outcomes of Azilsartan, angiotensin receptor blocker on castration-resistant prostate cancer
Not Applicable
- Conditions
- castration-resistant prostate cancer
- Registration Number
- JPRN-UMIN000012656
- Lead Sponsor
- Shinshu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. allergic to Azilsartan 2. angiotensin receptor blocker has been already prescribed 3. informed consent has not been obtained
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change in the prostate specific antigen
- Secondary Outcome Measures
Name Time Method